STRS Ohio’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-620
Closed -$16K 2176
2020
Q3
$16K Hold
620
﹤0.01% 2106
2020
Q2
$12K Hold
620
﹤0.01% 2083
2020
Q1
$9K Hold
620
﹤0.01% 1942
2019
Q4
$10K Hold
620
﹤0.01% 2007
2019
Q3
$15K Hold
620
﹤0.01% 1997
2019
Q2
$18K Buy
+620
New +$24.3K ﹤0.01% 2035

Other funds holding CKPT

STRS Ohio's CKPT Position: Q4 2020 in Review

STRS Ohio sold out of Checkpoint Therapeutics (CKPT) in Q4 2020, closing a stake of 620 shares — an estimated $16K sold.

STRS Ohio first reported a position in CKPT in Q2 2019 and held it in 6 quarters. The position peaked at $18K in Q2 2019. 62 funds tracked by Wall St. Rank hold CKPT as of Q4 2020.

  • STRS Ohio reported no remaining Checkpoint Therapeutics position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 620 Checkpoint Therapeutics shares in Q4 2020, an estimated $16K.
  • STRS Ohio first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 6 quarters.
  • STRS Ohio's Checkpoint Therapeutics position peaked at $18K in Q2 2019.
  • 62 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.